SGLT2 Inhibitors Nudge Hemoglobin: More Blood or Less Water?
Key Takeaway Across 85 randomized trials involving 70,543 patients, SGLT2 inhibitors raised hemoglobin by about 0.60 g/dL and hematocrit by about 2.36% more than…
Your Source for Real-Time Medical Insights, Verified by Experts.
Key Takeaway Across 85 randomized trials involving 70,543 patients, SGLT2 inhibitors raised hemoglobin by about 0.60 g/dL and hematocrit by about 2.36% more than…
Key Takeaway In a 2,915-patient analysis from the ATAMIS trial, adding clopidogrel to aspirin cut the odds of a stroke worsening during its first…
Key Takeaway Young adults with advanced coronary calcification cannot be considered low risk, even when traditional 10-year risk calculators suggest otherwise. Among nearly 13,000…
Never miss a critical medical brief.
Key Takeaway In patients remaining free of atrial fibrillation recurrences for one year following catheter ablation, discontinuing oral anticoagulation was not associated with accelerated…
Key Takeaway In a study of 2,276 US patients with atrial fibrillation who survived a bleeding stroke, 59.8% were restarted on blood thinners within…
Key Takeaway An atlas of more than 375,000 endothelial cells drawn from 12 human tissues shows that the inner lining of our blood vessels…
Key Takeaway In a post hoc analysis of 340 patients from the randomized ATTENTION trial, mechanical thrombectomy for basilar artery occlusion lost its statistical…
Key Takeaway Until now, tirzepatide's cardiovascular benefit could only be measured against another active drug. By mathematically anchoring SURPASS-CVOT to REWIND, this analysis estimates…
Key Takeaway A new consensus document published in the European Heart Journal urges emergency medical technicians and emergency physicians to classify acute heart failure…
Key Takeaway In a 510-patient imaging study drawn from the CONVINCE trial, stroke and TIA survivors whose CT scans showed high-risk carotid plaque (a…